Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women
NCT ID: NCT03558828
Last Updated: 2025-08-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
301 participants
INTERVENTIONAL
2018-08-24
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
NCT01280812
Women's Walking Program
NCT01700894
Effectiveness of an Intensive Intervention to Improve Physical Activity in Postmenopausal and Sedentary Women
NCT03872258
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors
NCT03523195
Individualized Motivational Print Materials to Encourage More Physical Activity
NCT00367029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Step1: Initial Treatment
Participants will be randomly assigned to one of the two initial treatment components: a) enhanced physical activity monitor only (physical activity monitor with goal setting and a physical activity prescription) treatment, or b) enhanced physical activity monitor+ motivational text messaging treatment for 8 weeks (early adoption phase). All participants will be given a physical activity step goal The initial treatment time period is from Weeks 1-8.
Step 1: PA Monitor
The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor.
Step 1: PA Monitor + Text
The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor.
In addition, these participants will receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
Step 2: Augmented Treatment
At Week 8, it will be determined if a women has met her physical activity step goal. If she has, then she will be classified as a responder, and will continue with the same initial treatment component for weeks 9-34 (later adoption).
If a woman has not met her physical activity step goal she will be classified as a non-responder. In addition to the initial treatment component non-responders to initial treatments will be randomly assigned to one of two augmented treatment components: a) personal calls, or b) group meetings for Weeks 9-34 (later adoption phase).
Step 2: PA Monitor with Calls
Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.
Step 2: PA Monitor with Meetings
Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.
Step 2: PA Monitor + Texts with Calls
Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.
Step 2: PA Monitor + Texts with Meetings
Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.
Step 3: Maintenance
At Weeks 35-50 (maintenance phase) all participants in the study return to an enhanced physical activity monitor only treatment component.
Step 3: PA Monitor
During Weeks 35-50, all women will receive enhanced physical activity monitors only.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Step 1: PA Monitor
The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor.
Step 1: PA Monitor + Text
The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor.
In addition, these participants will receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
Step 2: PA Monitor with Calls
Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.
Step 2: PA Monitor with Meetings
Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.
Step 2: PA Monitor + Texts with Calls
Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.
Step 2: PA Monitor + Texts with Meetings
Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment.
The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34.
In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.
In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.
Step 3: PA Monitor
During Weeks 35-50, all women will receive enhanced physical activity monitors only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 to 70
* Able to speak/read English
* Owns a smartphone with text messaging capability
* Willing to receive text messages at the proposed pace
* We will include participants who have Type 1 diabetes, or Type 2 diabetes with an A1C ≥ 9.0%, or have an A1C of ≥ 6.5% without a prior diabetes diagnosis, only if they have been given clearance by their health care provider
* Without a disability that inhibits walking as determined by the PAR-Q \& You (Physical Activity Readiness Questionnaire)
Exclusion Criteria
* Systolic BP ≥ 160 and/or diastolic BP ≥ 100
* Sufficiently or overly active, as determined by a physical activity monitor worn for one week, indicating averaging ≥ 7,500 steps per day ("somewhat active")
18 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Chicago
OTHER
Michigan State University
OTHER
National Institute of Nursing Research (NINR)
NIH
Rush University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Buchholz, PhD
Role: PRINCIPAL_INVESTIGATOR
Michigan State University, College of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rush University College of Nursing
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Buchholz SW, Ingram D, Wilbur J, Fogg L, Sandi G, Moss A, Ocampo EV. Bilingual Text4Walking Food Service Employee Intervention Pilot Study. JMIR Mhealth Uhealth. 2016 Jun 1;4(2):e68. doi: 10.2196/mhealth.5328.
Wilbur J, Miller AM, Fogg L, McDevitt J, Castro CM, Schoeny ME, Buchholz SW, Braun LT, Ingram DM, Volgman AS, Dancy BL. Randomized Clinical Trial of the Women's Lifestyle Physical Activity Program for African-American Women: 24- and 48-Week Outcomes. Am J Health Promot. 2016 May;30(5):335-45. doi: 10.1177/0890117116646342.
Buchholz SW, Wilbur J, Halloway S, Schoeny M, Johnson T, Vispute S, Kitsiou S. Study protocol for a sequential multiple assignment randomized trial (SMART) to improve physical activity in employed women. Contemp Clin Trials. 2020 Feb;89:105921. doi: 10.1016/j.cct.2019.105921. Epub 2019 Dec 30.
Daniel M, Buchholz SW, Schoeny M, Halloway S, Kitsiou S, Johnson T, Vispute S, Kapp M, Wilbur J. Effects of the COVID-19 pandemic on recruitment for the working women walking program. Res Nurs Health. 2022 Oct;45(5):559-568. doi: 10.1002/nur.22258. Epub 2022 Sep 12.
Buchholz SW, Daniel M, Kitsiou S, Schoeny ME, Halloway S, Johnson TJ, Vispute S, Wilbur J. Working Women Walking Program: A Sequential Multiple Assignment Randomized Trial. J Phys Act Health. 2025 May 6;22(7):778-792. doi: 10.1123/jpah.2024-0790. Print 2025 Jul 1.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT03558828
Identifier Type: REGISTRY
Identifier Source: secondary_id
DUNS: 068610245
Identifier Type: OTHER
Identifier Source: secondary_id
UEI: C155UU2TXCP3
Identifier Type: OTHER
Identifier Source: secondary_id
EIN: 1362174823A1
Identifier Type: OTHER
Identifier Source: secondary_id
17053108-IRB01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.